ATALANTA-1 data presented at ASH 2025 showed remarkable response rates and rapid manufacturing with an investigational autologous CAR T-cell therapy.
Muscat, Oman – TechBridge MEA, a leading Channel Value-Added Distributor (CVAD) specializing in mobility, cybersecurity, and networking solutions, today announced the opening of its newest office in ...
Strategic Partnership Addresses Growing Cybersecurity Threats and Regional Compliance Requirements in MEA Market Dubai, UAE: TechBridge Distribution MEA, a premier technology distributor and the ...
Citrix added a handful of offerings to its NetScaler platform designed to strengthen enterprise data security. Chief among the updates is support for post-quantum cryptography (PQC). Initially teased ...
Citrix, a business unit of Cloud Software Group, Inc., today announced two new offerings that help enterprises provide secure application access for their entire workforce across an evolving threat ...
Citrix offers innovative solution to support post-quantum cryptography (PQC) in NetScaler, as well as announcing CVAD 2507 Long Term Service Release (LTSR) and new annual release cadence FORT ...
1 School of Nursing and Midwifery, Griffith University, Nathan, Queensland, Australia 2 NHMRC Centre of Research Excellence in Nursing, Menzies Health Institute Queensland, Nathan, Queensland, ...
Hosted on MSN
AP Top Stories April 8 A
Here's the latest for Monday, April 8th: China promises tariff countermeasures; Trump says U.S. and Iran holding nuclear negotiations; Supreme Court rules administration can use 18th century law for ...
"The giant cyclic peptide is referred to as 'NeoBiologics' in the sense that it is a new biological agent that has not existed before. It will also be possible to develop new drugs by creating various ...
These findings highlight the need for resource-sensitive guidelines and more research in resource-limited settings, as well as improved education for outpatient CVAD management and dissemination of ...
Navi plans to conduct a further capital raise later this year to support its device’s access onto the US market. Image credit: Navi. The US Food and Drug Administration (FDA) has granted 510(k) ...
The results of this study strengthen the case that the mixing method is at least as effective as the standard discard method for CVAD blood specimen collection. The mixing method for central venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results